MAPK3 and lung carcinoma: Thus, in our in vitro model, we show that Mcp-1 is increased following MAPK activation (P38 and ERK1/2), and gap junction dysregulation, all evidence for 1-MeA’s potential to contribute to the early signaling events involved in promoting lung cancer.